Yayınlanmış 1 Ocak 2017
| Sürüm v1
Dergi makalesi
Açık
A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer
Oluşturanlar
- 1. Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey
- 2. Antalya Educ & Res Hosp, Dept Surg Gastroenterol, Antalya, Turkey
- 3. Izmir Univ Econ, Fac Med, Izmir, Turkey
- 4. Ankara Numune Training & Res Hosp, Dept Surg 5, Ankara, Turkey
- 5. Yuksek Ihtisas Training & Res Hosp, Dept Gastroenterol Surg, Ankara, Turkey
- 6. Chaim Sheba Med Ctr, Dept Gen & Oncol Surg Surg C, Tel Hashomer, Israel
- 7. Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
Açıklama
Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers.
Dosyalar
bib-749a0ceb-d280-4614-8e18-eb0deb713ca1.txt
Dosyalar
(317 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:d712f1550312c3089af61767705311a0
|
317 Bytes | Ön İzleme İndir |